Haruko Fujii
- Reproductive Medicine top 5%
- Obstetrics and Gynecology top 5%
- Molecular Biology
- Cellular and Molecular Neuroscience
- Neurology
- Co-authors
- Masafumi KoshiyamaMasumi YoshidaHiroshi FujiwaraShinya YoshiokaYukiyasu SatoHidetaka NannoNobuo KoharaTetsuya Shimizu
- Topics
- Ovarian cancer diagnosis and treatment (4 papers)Cancer therapeutics and mechanisms (4 papers)Axon Guidance and Neuronal Signaling (3 papers)
- Journals
- The LancetNeurologyEndocrinology
- Partner nations
- Japan
In The Last Decade
Haruko Fujii
19 papers receiving 349 citations
Peers
Comparison fields: 5 of 56
- Reproductive Medicine 137
- Obstetrics and Gynecology 113
- Molecular Biology 89
- Cellular and Molecular Neuroscience 73
- Neurology 71
Countries citing papers authored by Haruko Fujii
This map shows the geographic impact of Haruko Fujii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruko Fujii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruko Fujii more than expected).
Fields of papers citing papers by Haruko Fujii
This network shows the impact of papers produced by Haruko Fujii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruko Fujii. The network helps show where Haruko Fujii may publish in the future.
Co-authorship network of co-authors of Haruko Fujii
This figure shows the co-authorship network connecting the top 25 collaborators of Haruko Fujii. A scholar is included among the top collaborators of Haruko Fujii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruko Fujii. Haruko Fujii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 22 | |
| 3 | 31 | |
| 4 | 34 | |
| 5 | 8 | |
| 6 | 4 | |
| 7 | 63 | |
| 8 | 10 | |
| 9 | Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas. | 23 |
| 10 | 7 | |
| 11 | Correlation between Topo II alpha expression and chemosensitivity testing for Topo II-targeting drugs in gynaecological carcinomas. | 19 |
| 12 | Chemosensitivity testing of irinotecan (CPT-11) in ovarian and endometrial carcinomas: a comparison with cisplatin. | 9 |
| 13 | 12 | |
| 14 | 5 | |
| 15 | 22 | |
| 16 | 12 | |
| 17 | 11 | |
| 18 | 66 | |
| 19 | [Acute myocardial infarction induced by lung cancer chemotherapy with cisplatin and etoposide]. | 4 |
About Haruko Fujii
Haruko Fujii is a scholar working on Microbiology, Reproductive Medicine and Obstetrics and Gynecology, having authored 19 papers that have together received 368 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (4 papers), Cancer therapeutics and mechanisms (4 papers) and Axon Guidance and Neuronal Signaling (3 papers). The work is most often cited by research in Reproductive Medicine (137 citations), Microbiology (11 citations) and Obstetrics and Gynecology (113 citations). Haruko Fujii has collaborated with scholars based in Japan. Frequent co-authors include Masafumi Koshiyama, Masumi Yoshida, Hiroshi Fujiwara, Shinya Yoshioka, Yukiyasu Sato, Hidetaka Nanno, Nobuo Kohara, Tetsuya Shimizu, Takahiro Mezaki and Jun Kimura. Their work appears in journals such as The Lancet, Neurology and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.